Condition deep-dive · 6 min read

Chronic inflammation supplement protocol — what actually moves CRP and inflammatory markers

Updated 2026-05-11 · Reviewed by SupplementScore editors · No sponsorships

"Chronic low-grade inflammation" is a real phenomenon — elevated hs-CRP, IL-6, and TNF-α associated with adiposity, sedentary behaviour, sleep deprivation, and many chronic diseases — but it's not a diagnosis on its own. It's a marker of underlying biology, mostly metabolic and lifestyle-driven. Supplements that move CRP modestly include omega-3 EPA/DHA, curcumin in bioavailable form, and vitamin D in deficient users. They are small effects compared to weight loss, exercise, sleep optimisation, and diet quality — the actual drivers of inflammatory status.

Read this first. Persistent CRP elevation in the absence of obvious metabolic/lifestyle drivers should be evaluated rather than supplement-treated. Causes include autoimmune disease (rheumatoid arthritis, lupus, IBD), chronic infection, occult malignancy, and many others. CRP > 10 mg/L sustained, particularly with constitutional symptoms (weight loss, night sweats, fatigue, fever), needs primary care or specialist work-up. "Inflammation" as a marketing concept is not the same as inflammation as a medical condition.

What actually has trial evidence on inflammatory markers

Tier 1 evidence · Best-established

Omega-3 (EPA/DHA)

1–3 g EPA+DHA combined/day with a fatty meal

The most consistently effective supplement on CRP and other inflammatory markers across meta-analyses. EPA-dominant preparations have somewhat better inflammatory marker effects than DHA-dominant. Effect size on hs-CRP is small-to-moderate (~0.5–1 mg/L reduction in elevated baseline). Real but unimpressive compared to weight loss or exercise.

Tier 2 evidence · Bioavailable form essential

Curcumin (bioavailable form: phytosome, BCM-95, or piperine-enhanced)

500 mg b.i.d. of a bioavailable curcumin preparation

Curcumin's anti-inflammatory effect operates through NF-κB inhibition, COX-2 modulation, and other pathways. Native curcumin from turmeric powder has very poor bioavailability — supplements without a bioavailability-enhancement strategy don't deliver useful exposure. Phytosome (Meriva), BCM-95, or piperine-co-administered curcumin produce meaningful plasma exposure. Effect on CRP is modest in trials; particularly studied in osteoarthritis and metabolic syndrome.

Tier 1 evidence · In confirmed deficiency

Vitamin D3 (to target)

2,000–4,000 IU/day to a 25-OH-D target of 30–50 ng/mL

Vitamin D deficiency is associated with elevated inflammatory markers; repleting deficiency modestly reduces CRP in deficient users. Supplementation above the deficient range does not further reduce inflammation. Test 25-OH-D first.

Tier 2 evidence · Anti-resolving signal

Tart cherry concentrate (Montmorency)

8–16 oz cherry juice or equivalent in concentrate, daily

Anthocyanin-rich; trial evidence on exercise-induced inflammation and muscle soreness is reasonable. CRP effects in chronic settings are smaller. Reasonable layered onto exercise-recovery routines; not a primary inflammatory-marker tool.

What dominates over supplements — and matters far more

Body composition — particularly visceral adiposity — adipose tissue secretes inflammatory cytokines; weight loss of even 5–10% body weight produces larger CRP reductions than any supplement.
Aerobic exercise — regular aerobic activity at moderate intensity lowers chronic inflammatory markers; the effect is dose-related.
Sleep quality and quantity — sleep restriction acutely elevates IL-6 and CRP; chronic short sleep is independently associated with elevated inflammatory markers.
Mediterranean-pattern diet — vegetables, fruit, legumes, fish, olive oil, modest dairy, modest wine if alcohol is consumed at all. The PREDIMED trial demonstrated CV benefit and modest CRP reduction.
Smoking cessation — major modifiable driver of systemic inflammation.
Periodontal disease treatment — significant local source of chronic systemic inflammation; treating it lowers CRP.
Glycemic control — chronic hyperglycaemia drives inflammation; HbA1c control in diabetic patients reduces inflammatory markers.
Stress modulation — chronic psychological stress drives inflammatory signalling.

What to skip

"Anti-inflammatory" multi-ingredient blends — sub-therapeutic doses of many ingredients; single-ingredient products at trial-cited doses are better value.
High-dose turmeric powder (uncomplexed) — bioavailability is too low to deliver useful curcumin exposure; you'd need extraordinary amounts.
"Cellular detox" and "inflammation cleanse" protocols — unsupported.
Boswellia / ginger / quercetin as monotherapy for elevated CRP — each has small inflammatory marker signals in specific conditions (e.g., boswellia in OA); none is a meaningful tool for general "chronic inflammation."
Mega-dose vitamin C — does not reduce inflammation in non-deficient adults; can cause GI upset.
NSAIDs for "general inflammation" — NSAIDs reduce inflammation but are not appropriate chronic baseline use; cardiovascular, renal, and GI side effects are real.
"Adaptogen" stacks marketed as anti-inflammatory — small signals in some adaptogens; not the right tool for chronic low-grade systemic inflammation.

What to track

High-sensitivity CRP (hs-CRP) is the standard accessible inflammatory marker; values: < 1 mg/L low cardiovascular risk, 1–3 mg/L average, > 3 mg/L elevated, > 10 mg/L suggests acute inflammation or chronic disease and merits work-up. Single CRP values are highly variable; trend over 2–3 measurements separated by 2+ weeks. Reassess at 3 months of any inflammation-targeted protocol. Weight, waist circumference, fasting glucose, and lipid panel are more practical trackers because they also identify the upstream drivers.

Practical quick-start. If hs-CRP is elevated and a specific cause hasn't been identified: weight loss to a healthier BMI (5–10% reduction has measurable CRP effect), 150+ minutes/week of moderate aerobic exercise, Mediterranean-pattern diet, sleep 7–8 hours, smoking cessation. For the supplement layer: omega-3 1–2 g EPA+DHA/day + vitamin D3 to target if deficient + bioavailable curcumin 500 mg b.i.d. Reassess hs-CRP at 3 months. If CRP remains elevated without obvious driver, primary care evaluation.